As 2024 approaches, it’s anyone’s guess whether an already complex health care ecosystem gets to turn the corner on the mixed legacies of 2023—including record high prices on new blockbuster medications coupled with drug shortages on existing generics, persistent staff shortages and battered hospital margins, and a continued emphasis on value-based care programs by insurers.
A simple weekly electronic symptom check-in with a care team significantly improves the quality of life for individuals undergoing treatment for advanced cancer, according to the results of a trial led by Alliance Foundation Trials.
